Skip to main content
. 2020 Aug 19;10:1119. doi: 10.3389/fonc.2020.01119

Figure 1.

Figure 1

The relationship between the aberrant expression of RNA:m5C methyltransferases and clinicopathological characteristics of gliomas in the CGGA and TCGA datasets. (A,B) The differential expression of seven RNA:m5C methyltransferases with different WHO grades in gliomas. (C,D) The significant differential expression of RNA:m5C methyltransferases stratified by WHO grade in gliomas. (E,F) The differential expression of RNA:m5C methyltransferases stratified by IDH-mutant status in low-grade gliomas. Significance: *P < 0.05, **P < 0.01, ***P < 0.001.